Decrease in the haemoglobin level in haemodialysis patients undergoing antiandrogen therapy.
Teruel
J L
JL
Servicio de Nefrología, Hospital Ramón y Cajal, Madrid, Spain.
Cano
T
T
Marcén
R
R
Villafruela
J J
JJ
Rivera
M
M
Fernández-Juarez
G
G
Ortuño
J
J
D000368:Aged; D000726:Androgen Antagonists / Q000008:administration & dosage*; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005485:Flutamide / Q000008:administration & dosage; D006454:Hemoglobins / Q000032:analysis*; D006801:Humans; D016729:Leuprolide / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D011471:Prostatic Neoplasms / Q000188:drug therapy; D006435:Renal Dialysis
D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal; D006454:Hemoglobins; D005485:Flutamide; D016729:Leuprolide